NEJMÊÙ¶¯²ñ2003 Âè3²ó03/02/05 ¼Â»Ü A¥×¥ê¥ó¥È ôÅö: ´äº´ ·ò»Ë (tiwasa-tky@umin.ac.jp)
Case 1-2003: A 43-Year-Old Man with Fever and Night Sweats ¡ÊVolume 348(2): 151-161¡Ë
¨¡¨¡¨¡È¯Ç®¤È¿²´À¤¬Ç§¤á¤é¤ì¤¿43ºÐÃËÀ­¨¡¨¡¨¡

¡Ú´µ¼Ô¡Û 43ºÐÃËÀ­
¡Ú¼çÁʡ۠ȯǮ¡¤¿²´À¡¤ÂνŸº¾¯¡¤Æ¬ÄË
¡Ú¸½ÉÂÎò¡Û
  ´µ¼Ô¤Ï4¥ö·îÁ°¤ËU.S.A.¤Ë°Ü½»¤·¤¿¤Ð¤«¤ê¤Î¥â¥í¥Ã¥³¿Í¤Ç¡¤È¯¾ÉÁ°¤Î·ò¹¯¾õÂ֤ϰÂÄꤷ¤Æ¤¤¤¿¡¥
  Æþ±¡¤Î4¥ö·îÁ°¤«¤é¿²´À¡¤3¥ö·îÁ°¤«¤éÁ´¿È¤Î´ØÀáÄˤ¬½Ð¸½¤·¡¤¸½ºß¤Þ¤Ç·Ñ³¤·¤Æ¤¤¤ë¡¥Æþ±¡2¥ö·îÁ°¡¤ÇØÉôÄˤΤ¿¤á°û¿©Å¹¤òÂ࿦¤·¤¿¡¥¤Þ¤¿¡¤ºÇ¶á(´ü´Ö¤ÏÉÔÌÀ)4¡Á5kg¤ÎÂνŸº¾¯¤òǧ¤á¤¿¤È¤¤¤¦¡¥
  Æþ±¡3½µ´ÖÁ°¤Ë¾±¡¤Ë¤Æ¹üÌ©ÅÙ¬Äê¤ò»Ü¹Ô¡¤¹üÁÆò¢¾É¤È¿ÇÃǤµ¤ìalendronate¤Èrofecoxib¤ò½èÊý¤µ¤ì¤ë¡¥·ì±Õ¸¡ºº¤Ë¤ÆESR 59mm/h.¡¤·ìÇ¢(+++)¡¤·ìÃæ¥Æ¥¹¥È¥¹¥Æ¥í¥ó·ÚÅÙÄã²¼¡¤·ìÃæ25(OH)¥Ó¥¿¥ß¥óD3·ÚÅÙÄã²¼¤òǧ¤á¤ë¤â¡¤Ca, Mg, P, ALP, BUN, Cre, TSH¤ÏÀµ¾ïÈÏ°ÏÆâ¤Ç¤¢¤Ã¤¿¡¥¥¨¥³¡¼¸¡ºº¤Ë¤Æ¿Õ·ëÀФòǧ¤á¤Ê¤«¤Ã¤¿¡¥
  Æþ±¡2½µ´ÖÁ°¤è¤êƬÄˤÈȯǮ¤¬½Ð¸½¡¤¶á°å¤Ç½èÊý¤µ¤ì¤¿Ìô(¾ÜºÙÉÔÌÀ)¤òÉþÍѤ¹¤ë¤â¼ý¤Þ¤é¤º¡¤MGH¤ò¼õ¿Ç¤·¤¿¡¥¤Ê¤ªÍ象¤¹¤ëÄ«¤ÎÂβ¹¤Ï40.1¡î¤Ç¤¢¤Ã¤¿¡¥·ë³Ë¤Î´û±ý¤Ï¤Ê¤¯¡¤ºÇ¶á¤Îι¹Ô¡¤´¶À÷¾É´µ¼Ô¤äưʪ¤È¤ÎÀÜ¿¨¤Ï¤¤¤º¤ì¤â(-)¡¥
¡Ú´û±ýÎò¡Û
Æõ­¤¹¤Ù¤­»ö¹à¤Ê¤·
¡ÚÀ¸³èÎò¡Û alcohol (-), cigarettes (-), HIV´¶À÷¤Îrisk factor (-)
¡Ú²È²Îò¡Û Â©»Ò(8ºÐ)¡§·ë³Ë¤Î´û´¶À÷
¡ÚÆþ±¡»þ¸½¾É¡Û
<VITAL SIGNS> BT 38.9¡î, BP 110/60 mmHg, PR 96 /min irreg., RR 15 /min, SpO2 97 %(room air)
<GENERAL> ³±ÓÖ(-)¡¤áâ(-)¡¤Ó½·ì(-)¡¤¸ÆµÛº¤Æñ(-)¡¤°­¿´(-)¡¤ÓÒÅÇ(-)¡¤²¼Î¡(-)
<NECK> ·Ú¤¤¹àÉô¹Åľ(+)¡¤Kernig's sign(-), Brudzinski's sign(-)
<HEART> ­µ¢ª¡¤­¶¢ª¡¤­·(-)¡¤­¸(-)
<LUNG> lung sound: clear
<ABDOMEN> n.p.
<EXTREMITIES> well perfused, edema (-), clubbing (-)
<SKIN> ¹ÈÈÃ(-)¡¤äöà¥(-)¡¤¥ê¥ó¥ÑÀá¼ðı(-)
¡ÚÆþ±¡»þ¸¡ºº½ê¸«¡Û(Table 1¡¤Table 2¡¤Table 3¤ò»²¾È)
<CBC> WBC 7.5¡ß103/mm3 (Neu 69%, Mono 9%, Lym 22%), Ht 38.5% (MCV 84¦Ìm3), Plt 29.5¡ß104/mm3
<CHEMISTRY> Glu 177mg/dl, iP 1.8mg/dl(low), UA 1.9mg/dl(low), T.Chol. 148mg/dl, HDL 20mg/dl(low), LDL 108mg/dl, TG 98mg/dl, AMY 130U/l, TP 7.3g/dl, Alb 3.0g/dl, Na 128mM, K 3.3mM, Cl 98mM, HCO3 27.6mM, CK 50U/l(low), LDH 376U/l, BUN, Cre, T.Bil, D.Bil, Ca, Mg, AST(GOT), ALT(GPT), LIP, ALP: w.n.l
<COAGULATION> PT 14.3 sec. (Àµ¾ïÃÍ11.5-13.3), PTT w.n.l.
<U/A> Pro(+), RBC 10-20/hpf, WBC 0-2/hpf, bacteria Few, Na 109mM, K 57.2mM, Cl 130mM, osmorality 717mOsm/kg
<CXR> lung fields: Á´ÇÙÌî¤ËÀг¥²½¤·¤¿Æù²ê¼ð(+), ¾åÍդν̾®(+), ÅÀ¾õ±¢±Æ(+), ´ð¼Á²½(-), ¥ê¥ó¥ÑÀá¼ðı(-), ¶»¿å(-), heart: n.p.
<AXR> º¸¾åÊ¢Éô¤Ë¾®Ä²¤Î¥ë¡¼¥×¾õ³ÈÄ¥Áü(+)
<¶»Éô¤±ÆCT> (Fig. 1¤ò»²¾È)
  Â¤±ÆºÞ¤Ï·Ð¸ýŪ¤È·ÐÀÅ̮Ū¤ËÅêÍ¿¤µ¤ì¤¿¡¥
  ±¦¤Î˵µ¤´É»Ù¥ê¥ó¥ÑÀá(¦Õ8mm)¤È¡¤µ¤´Éʬ´ôÉô¥ê¥ó¥ÑÀá([A]Ìð°õÉô; ¦Õ13mm)¤òǧ¤á¤ë¡¥½Ä³Ö¤Ë¤Ï¾¤Ë°Û¾ï¤òǧ¤á¤º¡¤¶»Ëì¹Ð¤âÀµ¾ï¡¥Àг¥²½¤·¤¿Æù²ê¼ð2¸Ä(¦Õ9mm, ¦Õ6mm)¤¬±¦ÇÙÀí¶è¤È¸å¾åÇÙ¶è¤Ëǧ¤á¤é¤ì¡¤¤½¤ì¤¾¤ì¤Î·ëÀᤫ¤é¶»Ëì¤Ë¤¤¤¿¤ëÀþ¾õ¤ÎÉÔÆ©ÌÀ°è¤¬Ç§¤á¤é¤ì¤ë¡¥Á´Ç٤˾®·ëÀá±Æ¤¬Ç§¤á¤é¤ì¡¤ºÇÂç¤Î¤â¤Î(¦Õ2.8mm)¤ÏÆâÉô¤Î¶õƶ²½¤òȼ¤¤±¦¤Î¸åÇÙÄì¶è¤Ë°ÌÃÖ¤·¤Æ¤¤¤ë¡¥·ëÀá±Æ¤Ë¤Ï2¼ïÎढ¤ê¡¤¥¤) ÌÀÎƤʾ®·ëÀá±Æ¤ÏξÇÙ¤ÎÁ´°è¤Ë¶Ñ°ì¤ËʬÉÛ¤·¤Æ¤¤¤ë([C]; ²¼ÍÕ¾åÉôÃÇÌÌÁü¡¤ÇÙÌî¾ò·ï¡¤¤ò»²¾È)¤Î¤ËÂФ·¡¤¥í) "tree-in-bud" type±¢±Æ¤Ï¾®ÍÕÃæ¿´À­¤Ç¤¢¤ê¡¤º¸ÇÙ¾åÍÕ¤ª¤è¤Óº¸ÇÙ²¼ÍդξåÉô¤òÃæ¿´¤ËʬÉÛ¤·¤Æ¤¤¤ë([B]Ìð°õÉô; º¸ÇÙ¾åÍÕ¤Î"tree-in-bud" type±¢±Æ)¡¥¤Ê¤ª¡¤°ìÉô¤Ë·ÚÅ٤ε¤´É»Ù³ÈÄ¥¤òǧ¤á¤¿¡¥
<ƬÉôñ½ãCT>
¾åÌð¾õÀÅ̮ƶÆâÉô¤Ëlow-attenuation¤Ê¹½Â¤Êª¤òǧ¤á¤¿¡¥Æ¬³¸¹ü¤ËÇÈ·Á·ÁÀ®¤òȼ¤Ã¤Æ¤ª¤ê¡¤ÆͽФ·¤¿¥¯¥âËìðùγ¤Ç¤¢¤í¤¦¤È¹Í¤¨¤é¤ì¤ë¡¥
<¹øÄÇÀü»É>
¶Ï¤«¤Ë²«¿§¤¬¤«¤Ã¤¿Ç¾ÀÔ¿ñ±Õ¤¬ºÎ¼è¤µ¤ì¤¿¡¥RBC 6/mm3, WBC 107/mm3 (Neu 84%, Lym 14%), Glu 26mg/dl, TP 382mg/dl, ¡¡¶À¸¡¤Ç¤Ï¹³»À¶Ý¤ä¤½¤Î¾¤Î¹½Â¤Êª¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡¥ÇÝÍܤÏÄó½ÐÃæ¡¥
 
¡ÚÆþ±¡¸å·Ð²á¡Û
Æþ±¡¸å¡¤¶»Éô¤±ÆCT¤ª¤è¤ÓƬÉôñ½ãCT¡¤¹øÄÇÀü»É¤¬»Ü¹Ô¤µ¤ì¤¿¡¥
(²¼¿Þ)
 
¤¢¤ë¿ÇÃÇŪ¼êµ»¤¬»Ü¹Ô¤µ¤ì¤¿¡¥